These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27709231)

  • 1. Novel Therapy of Hyperhomocysteinemia in Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementing Disorders.
    Hara J; Shankle WR; Barrentine LW; Curole MV
    J Nutr Health Aging; 2016; 20(8):825-834. PubMed ID: 27709231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease.
    Shankle WR; Hara J; Barrentine LW; Curole MV
    J Alzheimers Dis; 2016 Oct; 54(3):1073-1084. PubMed ID: 27567825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients.
    Kwok T; Wu Y; Lee J; Lee R; Yung CY; Choi G; Lee V; Harrison J; Lam L; Mok V
    Clin Nutr; 2020 Aug; 39(8):2399-2405. PubMed ID: 31787369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.
    McCleery J; Abraham RP; Denton DA; Rutjes AW; Chong LY; Al-Assaf AS; Griffith DJ; Rafeeq S; Yaman H; Malik MA; Di Nisio M; Martínez G; Vernooij RW; Tabet N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011905. PubMed ID: 30383288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between intake of B vitamins and cognitive function in elderly Koreans with cognitive impairment.
    Kim H; Kim G; Jang W; Kim SY; Chang N
    Nutr J; 2014 Dec; 13(1):118. PubMed ID: 25516359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
    de Jager CA; Oulhaj A; Jacoby R; Refsum H; Smith AD
    Int J Geriatr Psychiatry; 2012 Jun; 27(6):592-600. PubMed ID: 21780182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.
    Oulhaj A; Jernerén F; Refsum H; Smith AD; de Jager CA
    J Alzheimers Dis; 2016; 50(2):547-57. PubMed ID: 26757190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
    Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial.
    Scott TM; Rogers G; Weiner DE; Livingston K; Selhub J; Jacques PF; Rosenberg IH; Troen AM
    J Prev Alzheimers Dis; 2017; 4(3):174-182. PubMed ID: 29182708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients.
    Sun Y; Lu CJ; Chien KL; Chen ST; Chen RC
    Clin Ther; 2007 Oct; 29(10):2204-14. PubMed ID: 18042476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
    Farina N; Jernerén F; Turner C; Hart K; Tabet N
    Exp Gerontol; 2017 Dec; 99():146-150. PubMed ID: 29024723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
    Possemis N; Verhey F; Prickaerts J; Blokland A; Ramakers I
    Trials; 2024 Mar; 25(1):162. PubMed ID: 38438923
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.